HSR25-150: Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Health-Related Quality of Life (HRQOL) Events in Patients With Primary Advanced or Recurrent Endometrial Cancer Treated With First-Line Immunochemotherapy
Roles
Author
Document Type
Article
Publication Date
1-1-2025
Publication Title
Journal of the National Comprehensive Cancer Network
DOI
10.6004/jnccn.2024.7342
Recommended Citation
Nanda, R. K., Jones, D. T., Aboaid, H., Srinvasmurthy, R., Nguyen, K., Ta, J., Chuang, B. T., Myat, Y. M., & Thein, K. Z. (2025). HSR25-150: Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Health-Related Quality of Life (HRQOL) Events in Patients With Primary Advanced or Recurrent Endometrial Cancer Treated With First-Line Immunochemotherapy. Journal of the National Comprehensive Cancer Network, 23 (3.5), Article HSR25-150. https://doi.org/10.6004/jnccn.2024.7342
